Author: Giuseppe Gritti; Federico Raimondi; Diego Ripamonti; Ivano Riva; Francesco Landi; Leonardo Alborghetti; Marco Frigeni; Marianna Damiani; Caterina Micò; Stefano Fagiuoli; Roberto Cosentini; Ferdinando Luca Lorini; Fabrizio Fabretti; Jonathan Morgan; Benjamin M.J. Owens; Karan Kanhai; Jim Cowburn; Marco Rizzi; Fabiano Di Marco; Alessandro Rambaldi
                    Title: Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support  Document date: 2020_4_3
                    ID: ajurlkwr_33
                    
                    Snippet: This analysis is presented to inform the medical community of the potential role of siltuximab in treating patients with SARS-CoV-2 infection who develop pneumonia/ARDS requiring CPAP/NIV. A cohort study matching patients treated with siltuximab to those treated with standard therapy at our hospital is ongoing and will report full clinical outcome upon completion. With extended follow-up, we anticipate that the natural history of the disease shal.....
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: This analysis is presented to inform the medical community of the potential role of siltuximab in treating patients with SARS-CoV-2 infection who develop pneumonia/ARDS requiring CPAP/NIV. A cohort study matching patients treated with siltuximab to those treated with standard therapy at our hospital is ongoing and will report full clinical outcome upon completion. With extended follow-up, we anticipate that the natural history of the disease shall be better described.
 
  Search related documents: 
                                Co phrase  search for related documents- better describe and cohort study: 1
  - better describe and natural history: 1, 2
  - better describe and SARS infection: 1, 2
  - clinical outcome and cohort study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
  - clinical outcome and extended follow: 1
  - clinical outcome and medical community: 1, 2, 3, 4, 5, 6, 7
  - clinical outcome and natural history: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
  - clinical outcome and patient treat: 1, 2
  - clinical outcome and potential role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
  - clinical outcome and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
  - clinical outcome and standard therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
  - clinical outcome report and cohort study: 1
  - clinical outcome report and SARS infection: 1, 2, 3, 4, 5, 6
  - cohort study and disease natural history: 1
  - cohort study and extended follow: 1, 2, 3
  - cohort study and medical community: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
  - cohort study and natural history: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
  - cohort study and patient treat: 1
  - cohort study and potential role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date